XML 135 R117.htm IDEA: XBRL DOCUMENT v3.20.4
Segment Reporting - Reconciliation of Operating Earnings to Net Income (Details)
3 Months Ended 12 Months Ended
Jul. 31, 2020
USD ($)
Jan. 02, 2018
USD ($)
Sep. 30, 2019
USD ($)
store
Mar. 31, 2019
USD ($)
store
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Aug. 31, 2019
USD ($)
Mar. 09, 2018
USD ($)
Segment Reporting Information [Line Items]                  
Operating income (GAAP measure)         $ 13,911,000,000 $ 11,987,000,000 $ 4,021,000,000    
Amortization of intangible assets         2,341,000,000 2,436,000,000 1,006,000,000    
Acquisition-related transaction and integration costs         332,000,000 480,000,000 492,000,000    
(Gain) loss on divestiture of subsidiary         (269,000,000) 205,000,000 86,000,000    
Receipt of fully reserved ACA risk corridor receivable         (307,000,000) 0 0    
Store rationalization charges         0 231,000,000 0    
Impairments         0 0 6,149,000,000    
Impairment of long-lived assets         0 0 43,000,000    
Interest income on financing for the Aetna Acquisition         0 0 (536,000,000)    
Adjusted operating income         16,008,000,000 $ 15,339,000,000 11,261,000,000    
U.S. Department of Health and Human Services, ACA Risk Corridor Receivables [Member] | Settled Litigation                  
Segment Reporting Information [Line Items]                  
Gain contingency, unrecorded amount               $ 313,000,000  
Former gain contingency, recognized in current period, before tax         307,000,000        
Retail/ LTC                  
Segment Reporting Information [Line Items]                  
Store rationalization charges     $ 96,000,000 $ 135,000,000          
Impairments             6,149,000,000    
Number of under performing stores, planned closure | store     22 46          
RX Crossroads                  
Segment Reporting Information [Line Items]                  
(Gain) loss on divestiture of subsidiary             (725,000,000)    
RX Crossroads | Retail/ LTC | Discontinued Operations, Disposed of by Sale                  
Segment Reporting Information [Line Items]                  
(Gain) loss on divestiture of subsidiary             $ 86,000,000    
Proceeds from sale of subsidiary   $ 725,000,000              
Coventry Health Care Workers Compensation Business | Health Care Benefits | Discontinued Operations, Disposed of by Sale                  
Segment Reporting Information [Line Items]                  
(Gain) loss on divestiture of subsidiary         $ 269,000,000        
Proceeds from sale of subsidiary $ 850,000,000                
2018 Senior Notes                  
Segment Reporting Information [Line Items]                  
Debt issued in acquisition                 $ 40,000,000,000